Merger with Chanticleer (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Apr. 02, 2020 |
Aug. 31, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
|
| Number of common stock issued | 757,933 | |||
| Warrants issued during the period | 20,210 | 93,026 | ||
| Warrants exercise price | $ 29.32 | |||
| Number of common stock issued, value | $ 19,070,030 | $ 2,767,000 | ||
| Issuance of warrants | 186,161 | |||
| Minimum [Member] | ||||
| Warrants exercise price | $ 58.50 | |||
| Maximum [Member] | ||||
| Warrants exercise price | $ 1,820.00 | |||
| Spin-off Entity [Member] | ||||
| Decrease in additional paid-in capital | $ 6,000,000 | |||
| Common Stock [Member] | ||||
| Number of common stock issued | 547,639 | 2,338,435 | 346,759 | |
| Number of common stock issued, value | $ 6,000,000 | $ 233 | $ 35 | |
| X | ||||||||||
- Definition Decrease in additional paid-in capital. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|